Delivery Order SPE2DB22D2206-SPE2DB26FDS15
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,088.36 to AmerisourceBergen Drug Corp for the supply of Mounjaro (tirzepatide) 15 mg/0.5 mL pens on September 15, 2025. This firm fixed-price, non-set-aside delivery order, which is due for completion by September 16, 2025, represents a single transaction under AmerisourceBergen's larger pharmaceutical supply agreement with the federal government. The product will be delivered to AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a $3,537.17 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Mounjaro (tirzepatide) 5 mg/0.5 mL pens in 0.5 mL unit doses. The contract, which is a non-set-aside competitive award with an ultimate completion date of July 25, 2025, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $1,197.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mounjaro (tirzepatide) 10 mg/0.5 mL pens on August 25, 2025, with an ultimate completion date of August 26, 2025. This non-set-aside competitive award represents a pharmaceutical supply delivery executed through AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999 and extends through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Mounjaro (tirzepatide) 10 mg/0.5 mL pens valued at $13,934.62 on May 6, 2025, with completion scheduled for May 7, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion pharmaceutical supply vehicle running through...
- The Defense Logistics Agency awarded a $11,495.12 delivery order to AmerisourceBergen Drug Corp for Mounjaro (tirzepatide) 5 mg/0.5 mL pens on May 27, 2025, with completion scheduled for May 28, 2025. This competitively awarded, firm fixed-price contract requires delivery to the company's facility in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and...
- The Defense Logistics Agency awarded a $9,733.61 firm fixed-price delivery order to AmerisourceBergen Drug Corp on June 26, 2025, for the supply of Mounjaro (tirzepatide) 5 mg/0.5 ml pens. The contract is non-competitive with no set-aside designation and carries an ultimate completion date of June 27, 2025. AmerisourceBergen will fulfill this delivery order from its corporate office location in Conshohocken, Pennsylvania, serving the federal government's pharmaceutical supply requirements....
- The Defense Logistics Agency awarded a $3,771.95 delivery order to AmerisourceBergen Drug Corp for Mounjaro (tirzepatide) 15 mg/0.5 mL pens on June 3, 2025, with completion expected by June 4, 2025. This non-set-aside contract utilizes firm fixed pricing and is fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and...
- The Defense Logistics Agency awarded a delivery order valued at $4,081.35 to AmerisourceBergen Drug Corp for the supply of Mounjaro (tirzepatide) 15 mg/0.5 mL pens on September 10, 2025. This firm fixed price delivery order, with an ultimate completion date of September 11, 2025, represents a competitively awarded contract with no set-aside designation. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and serves as...
- The Defense Logistics Agency awarded a $14,843.53 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Mounjaro (tirzepatide) 15 mg/0.5 mL pens. The award, which carries an ultimate completion date of September 24, 2025, represents a non-competitive delivery order executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a...
- The Defense Logistics Agency awarded a delivery order valued at $11,125.48 to AmerisourceBergen Drug Corp for Mounjaro 5 mg/0.5 mL pens (tirzepatide injection), a diabetes medication, with completion targeted for September 15, 2025. This competitive, firm fixed-price delivery order represents a non-set-aside award to the pharmaceutical distributor's corporate office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB26FDS15Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro (tirzepatide) 15 mg/0.5 mL pens valued at $1,632.54 on October 20, 2025, with completion scheduled for October 21, 2025. This competitively awarded, non-set-aside delivery order uses firm fixed pricing and is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a pharmaceutical supply transaction under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp supplies an extensive portfolio of medications and medical supplies to support military and veteran healthcare systems. The SPE2DX IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to deliver brand-name and generic drugs, specialty medications, vaccines, and related medical supplies across multiple therapeutic domains to customers including the Defense Health Agency and U.S. Coast Guard. This specific delivery order for Mounjaro, a diabetes and weight management medication, exemplifies the company's role in supporting federal healthcare procurement needs through flexible and competitively awarded contract mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 10/20/25 |